System Chancellor John Sharp and Texas A&M President M. Katherine Banks announced their decision to reorganize and consolidate five commercialization offices.
Siemens recently unveiled an imaging device that promises to detect diseases earlier, allowing for earlier treatment to improve the outlook for patients.
Researchers are looking into drone delivery as a method to efficiently deliver testing kits while limiting contact between individuals.
Through cutting-edge technology, Texas A&M nursing students gain clinical experience before working directly with patients.
Sano Chemicals, founded by Professor of Biology Jim Smith, is focused on treating drug-resistant fungal and bacterial infections.
The Worlds Protect breathalyzer kiosk uses artificial intelligence to “smell” or detect COVID-19 on an exhaled breath. The next step is to make this technology more accessible.
The drug developed by Texas A&M and University of Texas MD Anderson Cancer Center scientists could be an effective treatment for COVID-19 and other illnesses.
A Texas A&M researcher and students hope to harness the thermal energy generated by body heat to power a small, electronic device capable of detecting fever in the wearer.
The study could be the first step toward creating portable systems for home use that can change oxygen supply depending on a patient’s needs.
The team will develop a platform to rapidly prototype and test thermally stable and highly efficient mRNA vaccines.